Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002403595 | SCV002709249 | likely benign | Hereditary cancer-predisposing syndrome | 2020-01-24 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV003097049 | SCV003280324 | likely benign | Multiple endocrine neoplasia, type 2 | 2022-06-07 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV003097049 | SCV004817395 | likely benign | Multiple endocrine neoplasia, type 2 | 2023-03-09 | criteria provided, single submitter | clinical testing |